Annual report pursuant to Section 13 and 15(d)

RELATED PARTY TRANSACTIONS (Details Narrative)

v3.7.0.1
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Jun. 24, 2016
Jan. 01, 2016
Oct. 21, 2015
Dec. 20, 2013
Jan. 31, 2017
Dec. 31, 2016
Feb. 28, 2017
Feb. 29, 2016
Mr. Andrew I. Sealfon [Member] | Lease Agreement [Member] | Aircraft [Member]                
Lease payments             $ 21,500 $ 21,500
Mr. Mark Pastreich [Member] | Lease Agreement [Member] | Building [Member]                
Monthly lease payments             11,042 11,042
Lease payments             132,504 132,504
Property taxes paid             48,455 47,954
Brad A. Sealfon [Member]                
Officer compensation         $ 7,744 $ 7,744    
Clinical Research & Support Services Consulting Agreement [Member] | Dr. Paul Mark Baker [Member]                
Amortization of deferred compensation cost             $ 28,000 $ 28,000
Clinical Research & Support Services Consulting Agreement [Member] | FREEDOM60 Syringe Infusion System [Member] | Dr. Paul Mark Baker [Member]                
Number of shares issued upon agreement       420,000        
Share price (in dollars per share)       $ 0.20        
Agreement term       3 years        
Consulting Agreement [Member] | Mr. Cyril Narishkin [Member]                
Monthly payment for agreement   $ 16,000 $ 16,000          
Description of payment terms  

Seventy-five percent was to be paid in cash and twenty-five percent was to be paid in shares of common stock.

Half is to be paid in cash and half is to be paid in shares of common stock.

         
Consulting Agreement [Member] | Mr. Cyril Narishkin (Consultant) [Member]                
Monthly payment for agreement $ 16,000              
Number of shares repurchased             96,542  
Value of shares repurchased             $ 43,393  
Officer compensation             $ 230,000